Author: admin

RVP Users’ Group: Omicron RVPs and their role in safe neutralization assessment | February 15th, 11am ET

Join this users’ group to learn about our extensive catalog of SARS-CoV-2 Reporter Virus Particles (RVPs, pseudotyped viruses) including Omicron, and how they enable researchers to rapidly test […]

Integral Molecular Adds Transgenic Humanized Mice to Expand its MPS Antibody Discovery Platform Through a Partnership with Alloy Therapeutics

PHILADELPHIA — Integral Molecular, the leader in discovering antibodies against multipass membrane proteins, has entered into an agreement to leverage Alloy Therapeutics’ transgenic humanized […]

Integral Molecular Adds Omicron to its Panel of 68 SARS-CoV-2 Reporter Virus Variants to Assess the Effectiveness of Vaccines and Therapeutics

PHILADELPHIA — Integral Molecular has developed the most extensive catalog of 68 variant SARS-CoV-2 Reporter Virus Particles (RVPs), now including Omicron, allowing researchers to […]

Integral Molecular Enters into Antibody License Agreement with AstraZeneca for Oncology Therapeutics

PHILADELPHIA —Integral Molecular, an industry leader in developing antibodies against membrane proteins, announced today that it entered into an exclusive worldwide antibody license agreement with AstraZeneca (LSE/STO/Nasdaq: […]

Integral Molecular and Integrated BioTherapeutics Collaborate to Engineer Broadly Protective Ebolavirus Vaccines

PHILADELPHIA – A collaboration between Integral Molecular and Integrated BioTherapeutics (IBT), two biotechnology companies with deep expertise in virology, has resulted in engineered proteins that may enable next-generation vaccines with broad protection against Ebola and related viruses.  With access to neutralizing Ebola antibodies discovered by IBT, Integral Molecular used Shotgun Mutagenesis—part of its GeneCanvas protein […]

Webinar: Combatting SARS-CoV-2 Variants: Neutralization Testing from Alpha to Mu

Date: November 30, 2021 Watch Video COVID-19 has united scientists with a shared mission, sense of collaboration, and urgency. Global lab meetings, prompt sharing […]

Philadelphia Biotech Integral Molecular Celebrates 20 Years of Innovation, Growth, and Community

PHILADELPHIA — Integral Molecular, a founding member of Philadelphia’s biotech community, celebrates its 20th anniversary as a leader in antibody discovery and virology. With […]

Webinar: Comprehensive Specificity Profiling of Antibody-Based Therapeutics Using the Membrane Proteome Array

Webinar Description: Rigorous specificity analysis is critical for drug development success, as even minimal off-target binding can lead to preclinical failures or serious adverse […]

Integral Molecular’s Extensive Collection of SARS-CoV-2 Reporter Virus Variants Supports the Clinical Development of Vaccines and MAbs Against Coronavirus

PHILADELPHIA — To aid in the clinical development of new vaccines and monoclonal antibodies (MAbs) effective against emerging and highly infectious coronavirus variants, Integral […]